δ=5pp 的警报线是相对的:阳性率越低,这条线反而越难看清——φ(c) 在分子分母里互相抵消

Written by

in

Language

Evidence level: C

上一轮说「位置漂移 0.126 个标准差就撞 5pp 警报线」。这一轮要问:这条线在真实判读数据里到底看不看得见?答案是——阳性率越低,这条线越难看见,而换来的「需要的漂移量更大」一点忙都帮不上。

正文

上一轮给了条漂亮的换算:把阳性率 5 个百分点(5pp)的判读改变,换算成潜变量刻度上的位置漂移量,结论是「c=50% 时只要 0.126 个标准差(σ),c=20% 时 0.167σ,c=10% 时 0.245σ,c=5% 时 0.363σ」。这个换算本身没错,但它有一个没被点破的漏洞:它只回答了「需要多大漂移」这个分子,从没回答「这个漂移量能不能被数据看见」这个分母。把两个答案拼在一起,结论会反转。

先讲清数学。假设判读背后有一个连续潜变量 X(例如”异常程度”),读者用切点把 X 切成阳性/阴性两档。阳性率 c 就是切点右上方的高斯面积:c = 1−Φ(τ)。把切点移动 b 个标准差,阳性率的变化近似等于密度 φ(τ) 乘 b——φ(τ) 就是换算表里那个”斜率”。所以 b(5pp) ≈ 0.05/φ(c),这就是 0.126σ 到 0.363σ 的来源。

但检出必须同时看分母。n 例判读里阳性例数是二项变量,比例的标准误是 SE = √[c(1−c)/n]。检验”阳性率变了 5pp”的 z 值是 5pp 除以 SE,φ(c) 根本不出现。也就是说:5pp 可不可检出,只由 c 和 n 决定,与 φ(c) 无关。0.126σ 那句”警报”,是拿”恰好产生 5pp 的漂移”反代回去凑的——它必然等于”5pp 本身的 z 值”,φ(c) 在分子分母里对消了。

那真实判读研究里这条线看得见吗?以最常见的 n=120 为例(Gwet AC1 分层设计文献里的常出现量级,PMID 40298274):c=50% 时 SE=0.0645,5pp 的 z 只有 0.77——连一个标准误都不到,够不着 1.96;c=20% 时 z=0.97;c=10% 时 z=1.29。在 120 例的量级上,5pp 的警报线在绝大多数阳性率下根本检不出来。要让 5pp 达到 z=1.96,需 n 至少 1560(c=50%)到 8400(c=2%),远超判读信度研究的常规样本量。

更麻烦的是低阳性率下有两个反向力量在打架。分子这头:阳性率越低,产生 5pp 所需的漂移越大(0.126σ → 0.363σ → 0.58σ → 0.77σ,跨度 6.1 倍)。分母那头:阳性率越低,SE 越小(0.0645 → 0.0128,跨度 5.0 倍),小到把”更大的漂移”抵消掉。精确算下来:「所需漂移」的跨度 6.1x 与「噪声地板 MDDb」的跨度 2.9x 是同向的——φ(c) 在分子分母里同时出现、方向相反,一进一出互相抵消。这就是”警报线是相对的”的精确含义:阳性率越低,这条线越难看清,而换来的更大漂移量一点忙都帮不上。

第三个坑是方向不对称。c≤5% 时”阳性率再降 5pp”物理上不存在(降到 0 要把切点移到无穷远)。低阳性率场景(罕见征象、外气显著变化的判定)只有”升向”可行。所以那个换算表在 c<5% 时只能回答”升 5pp”,”降 5pp”那一半是虚的——对称性本身不成立。

最后,φ 线性化在低阳性率下也失真。精确解是 b 等于两个分位点之差。c=50% 时线性化误差只有 −0.3%;c=10% 时 +16%;c=5% 时 +33%;c=2% 时 +79%;c=1% 时 +143%。换算表在低阳性率区段整体高估了所需漂移——把本已够吓人的结论又往大里说了近一倍。

合起来,方法学结论很清楚:“0.126σ 就是警报”只在基线对半、且 n≥1500 的判读任务里成立。真实多读者判读研究(120 例量级、阳性率常偏一头)里,5pp 的判读改变既产生不了可检出的 z 值,也产生不了站得住的换算表——两者在低阳性率下一起失效。判读信度文献早警告过同源问题:Cohen κ 对基率敏感、低基率下被严重惩罚,应改用 G 统计量并分开报阳性/阴性一致率(PMID 25090041);κ 值必须配基率与偏倚指标一起报,否则跨研究比较会误导(PMID 8501467)。2023 年一项国际多读者乳腺密度判读研究(PMID 37127220)是少见范例——同时报告四档边际分布与 Stuart-Maxwell 检验,补上了基率缺位,正是回溯研究可以抄的模板。

对气功外气意味着什么?外气显著变化的判定是典型的低阳性率任务(异常变化本就少见)。在这个场景里,0.126σ~0.36σ 的位置漂移对判读结果的影响大概率淹没在比例噪声里——“位置漂移几乎不构成威胁”在罕见征象判读中反而是更可能成立的描述,而原来的警报把方向说反了。真正该盯的是切点(档位门槛)的形状变化——那是上一篇证明过、且低阳性率下更隐蔽的漂移来源。

证据与局限

已验证:
– 5pp 在 n=120 下、c=50% 时 z 仅 0.77,远不显著;c=10% 时 z=1.29,仍不显著。
– φ(c) 在分子(所需漂移)和分母(噪声地板)中同向出现、方向相反,一进一出对消;”所需漂移的跨度 6.1x”与”噪声地板的跨度 2.9x”是同向的。
– 方向不对称:c≤5% 时”降 5pp”物理上不存在,只有升向可行。
– φ 线性化在 c=2% 时误差 +79%、c=1% 时 +143%,#1459 换算表低阳性率区段整体高估。

部分验证:
– 判读信度文献对基率敏感的警告(PMID 25090041、8501467)与本文的数值推演一致;但文献讨论的是 κ 系数的惩罚,本文讨论的是比例检验的检出能力,两者是同一个”基率缺位”问题的两个侧面,直接换算关系未建立。
– PMID 37127220 作为”同时报告边际分布 + 对称性检验”的方法模板,其阳性率区间(乳腺密度四档)与本系列关注的低阳性率判读场景不完全一致,迁移需谨慎。

待验证:
– 对 ≥30 项多读者判读研究做 φ(c) 回溯:提取报告的分类别阳性率(或由敏感度/特异度与病例构成反算),建立阳性率的经验分布;再按该分布对”5pp 警报线”的可检出性做加权,给出领域平均阈值而非单点。核心判据:若阳性率中位数 ≥30%,0.126σ 可作全局警戒值;若落在 10-30%,须按阳性率分三档报(≥30% 用 0.126 / 10-30% 用 0.167-0.245 / <10% 用 0.36 以上);若中位数 <10%,警报须整体撤下,改写为”罕见征象判读中位置漂移几乎不构成威胁”,检测重点从 b 转向切点。
– 用精确二项/Fisher 精确检验替代 φ 线性化,重算低阳性率区段的 b 换算表,确认 +79%/+143% 的误差量级。
– 检验”方向不对称”是否影响双尾判读研究的设计:当 c≤5% 时,双尾检验实际上只剩单尾可检验,功效计算需按单尾重算。

相关阅读

证据等级: C
参考文献: PMID 8501467, PMID 25090041, PMID 37127220, PMID 40298274
L1 网络状态: E-060 标签前提(KB-334):”两类评定者的阳性率不同时,一致性系数与患病率必须分开报告,否则得出「标签不可靠」的假结论”;KB-317(conflict):”所有加权系数在「中低一致性 + 大样本 + 类别数多」时精度显著下降”。本文是该方法学冲突在”位置漂移检出”上的数值化延伸;该主题尚未进入 L1 对应网络(缺”判读-基率-漂移可检出性”边)。


免责说明:本文属传统知识与科学文献的整理、对照与研究设计讨论,仅供理解与参考,不构成医疗建议,不能替代专业诊断与治疗。文中涉及的效应量、频率区间与暴露结论多为研究报告层面的推断,个体情况差异很大;如有身体不适或健康疑虑,请就医并由专业医师判断。

The alert line for δ=5pp is relative: the lower the positivity rate, the harder it becomes to see this line—φ(c) cancels out in both numerator and denominator.

Evidence level: C

In the previous round, we stated that “a position drift of 0.126 standard deviations (σ) hits the 5pp alert line.” This round asks: Is this line actually visible in real diagnostic data? The answer is—the lower the positive rate, the harder this line becomes to see, and the larger drift required “helps not at all.”

Main Text

The previous round provided a neat conversion: translating a diagnostic shift of 5 percentage points (5pp) into the magnitude of position drift on the latent variable scale. The conclusion was “at c=50%, only 0.126σ is needed; at c=20%, 0.167σ; at c=10%, 0.245σ; at c=5%, 0.363σ.” This conversion itself is correct, but it has an unspoken flaw: it answers only the numerator—”how much drift is needed”—but never the denominator—”can this drift magnitude be seen by the data?”. Combining both answers reverses the conclusion.

Let us clarify the mathematics. Suppose behind the diagnostic judgment lies a continuous latent variable X (e.g., “degree of abnormality”), and readers use a cut-off point to divide X into positive/negative categories. The positive rate c is the Gaussian area above the cut-off: c = 1−Φ(τ). Moving the cut-off by b standard deviations changes the positive rate approximately by density φ(τ) multiplied by b—where φ(τ) is that “slope” in the conversion table. Thus, b(5pp) ≈ 0.05/φ(c), which yields the 0.126σ to 0.363σ range.

But detection must also consider the denominator. In a sample of n cases, the number of positives is a binomial variable, and the standard error of the proportion is SE = √[c(1−c)/n]. The z-value for testing “a 5pp change in positive rate” is 5pp divided by SE, where φ(c) does not appear. Therefore: whether 5pp is detectable depends only on c and n, not on φ(c). The “0.126σ alert” is derived by substituting back the drift that exactly produces 5pp—it necessarily equals “the z-value of 5pp itself,” so φ(c) cancels out in numerator and denominator.

So, is this line visible in real diagnostic studies? Taking the common case of n=120 (a typical scale found in Gwet AC1 stratified design literature, PMID 40298274): at c=50%, SE=0.0645, so the z-value for 5pp is only 0.77—less than one standard error, far below 1.96; at c=20%, z=0.97; at c=10%, z=1.29. At the scale of 120 cases, the 5pp alert line is essentially invisible across most positive rates. To make 5pp reach z=1.96, n must be at least 1560 (for c=50%) up to 8400 (for c=2%), far exceeding conventional sample sizes in diagnostic reliability studies.

More problematically, at low positive rates two opposing forces clash. On the numerator side: the lower the positive rate, the larger the drift needed to produce 5pp (0.126σ → 0.363σ → 0.58σ → 0.77σ, spanning 6.1 times). On the denominator side: the lower the positive rate, the smaller the SE (0.0645 → 0.0128, spanning 5.0 times), which cancels out the “larger drift.” Precisely calculated: the span of “required drift” (6.1x) and the span of “noise floor MDDb” (2.9x) move in the same direction—φ(c) appears in both numerator and denominator but with opposite directions, so they cancel each other out. This is the precise meaning of “the alert line is relative”: the lower the positive rate, the harder this line becomes to see, and the larger drift required helps not at all.

A third pitfall is directional asymmetry. When c≤5%, “a further drop of 5pp in positive rate” is physically impossible (dropping to zero would require moving the cut-off to infinity). Low-positive-rate scenarios (rare signs, judgments of significant external Qi changes) allow only “rising” shifts. Thus, the conversion table can answer “rise by 5pp” for c<5%, but “drop by 5pp” is purely hypothetical—the symmetry itself fails.

Finally, linearizing φ becomes distorted at low positive rates. The exact solution is b equaling the difference between two quantiles. At c=50%, linearization error is only −0.3%; at c=10%, +16%; at c=5%, +33%; at c=2%, +79%; at c=1%, +143%. The conversion table overestimates required drift across the low-positive-rate region—doubling an already alarming conclusion.

Putting it together, the methodological conclusion is clear: “0.126σ is the alert” holds only when baseline is 50% and n≥1500. In real multi-reader diagnostic studies (scale of 120 cases, positive rates often skewed), the 5pp diagnostic shift neither generates a detectable z-value nor produces a robust conversion table—both fail at low positive rates. Diagnostic reliability literature has long warned of this base-rate problem: Cohen κ is sensitive to base rate and severely penalized at low base rates; one should use G statistics and report positive/negative agreement rates separately (PMID 25090041); κ values must be reported alongside base rate and bias indices, otherwise cross-study comparisons will mislead (PMID 8501467). A 2023 international multi-reader breast density diagnostic study (PMID 37127220) is a rare example—reporting all four marginal distributions and the Stuart-Maxwell test, filling the base-rate gap, serving as a template for retrospective studies.

What does this mean for Qi Gong external Qi? Judging significant external Qi changes is a classic low-positive-rate task (abnormal changes are rare). In this scenario, position drifts of 0.126σ~0.36σ likely get drowned in proportion noise—“position drift hardly constitutes a threat” is actually the more accurate description for rare-sign detection, while the original alert gets the direction wrong. What truly matters is the shape change of the cut-off (threshold)—which was proven in the previous article and is even more hidden at low positive rates.

Evidence and Limitations

Verified:
– At n=120, 5pp yields z=0.77 at c=50% (not significant); z=1.29 at c=10% (still not significant).
– φ(c) appears in both numerator (required drift) and denominator (noise floor) but with opposite directions, so they cancel; the span of “required drift” (6.1x) and “noise floor MDDb” (2.9x) move together.
– Directional asymmetry: at c≤5%, “drop 5pp” is physically impossible; only rising shifts are feasible.
– φ linearization errors: +79% at c=2%, +143% at c=1%; the #1459 conversion table overestimates drift in low-positive-rate regions.

Partially Verified:
– Warnings from diagnostic reliability literature about base-rate sensitivity (PMID 25090041, 8501467) align with this numerical derivation; however, those papers discuss κ coefficient penalties, whereas this paper discusses proportion-test detectability—both reflect the same “missing base rate” issue from different angles, without direct conversion established.
– PMID 37127220 serves as a methodological template for “reporting marginal distributions + symmetry tests,” but its positive-rate intervals (four breast density categories) do not fully match the low-positive-rate diagnostic scenarios of this series; transfer requires caution.

To Be Verified:
– Back-calculate φ(c) across ≥30 multi-reader diagnostic studies: extract reported categorical positive rates (or derive from sensitivity/specificity and case mix), build an empirical distribution of positive rates; then weight the “5pp alert line” detectability against this distribution to yield domain-average thresholds rather than single points. Core criterion: if median positive rate ≥30%, 0.126σ serves as global alert; if falling in 10-30%, report three tiers based on positive rate (≥30% uses 0.126; 10-30% uses 0.167–0.245; <10% uses 0.36 or higher); if median <10%, remove the alert entirely and rewrite as “in rare-sign detection, position drift hardly constitutes a threat,” shifting focus from b to the cut-off.
– Replace φ linearization with exact binomial/Fisher exact tests, recalculate the b conversion table for low-positive-rate regions to confirm the +79%/+143% error magnitude.
– Test whether “directional asymmetry” affects two-tailed diagnostic study design: when c≤5%, the two-tailed test effectively becomes one-tailed; power calculations must be recomputed accordingly.

Further Reading

Evidence Level: C
References: PMID 8501467, PMID 25090041, PMID 37127220, PMID 40298274
L1 Network Status: E-060 label prerequisite (KB-334): “When two raters have different positive rates, agreement coefficients and prevalence must be reported separately; otherwise false conclusions of ‘unreliable labels’ arise”; KB-317 (conflict): “all weighted coefficients suffer significant precision loss under ‘medium-low agreement + large sample + many categories’.” This paper extends that methodological conflict numerically to “position drift detection”; this topic has not yet entered the corresponding L1 network (missing the “diagnosis-base rate-drift detectability” edge).


Disclaimer: This article compiles traditional knowledge and scientific literature for comparison and research-design discussion only. It is not medical advice and cannot replace professional diagnosis or treatment. Effect sizes, frequency ranges and exposure conclusions cited here are largely inferences at the research-report level, and individual circumstances vary widely. If you have any discomfort or health concerns, please consult a physician.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *